TrendingVideosIndia
Opinions | CommentEditorialsThe MiddleLetters to the EditorReflections
UPSC | Exam ScheduleExam Mentor
State | Himachal PradeshPunjabJammu & KashmirHaryanaChhattisgarhMadhya PradeshRajasthanUttarakhandUttar Pradesh
City | ChandigarhAmritsarJalandharLudhianaDelhiPatialaBathindaShaharnama
World | ChinaUnited StatesPakistan
Diaspora
Features | The Tribune ScienceTime CapsuleSpectrumIn-DepthTravelFood
Business | My MoneyAutoZone
News Columns | Straight DriveCanada CallingLondon LetterKashmir AngleJammu JournalInside the CapitalHimachal CallingHill View
Don't Miss
Advertisement

PGIMER to resume walk-in patients for physical visit to New OPD from Monday

Unlock Exclusive Insights with The Tribune Premium

Take your experience further with Premium access. Thought-provoking Opinions, Expert Analysis, In-depth Insights and other Member Only Benefits
Yearly Premium ₹999 ₹349/Year
Yearly Premium $49 $24.99/Year
Advertisement

Tribune News Service
Chandigarh, September 24

Advertisement

In view of the current dip in Covid-19 patients, PGIMER has decided to resume walk-in patients for physical visit to the New OPD from Monday.

Advertisement

Accordingly, the following protocol will be followed in New OPD of PGIMER from Monday.

Registration for Tele-consultation in New OPD will be done from 8 am to 9 am on the same phone number as before i.e 0172-275991 which has 19 lines.  

Registration of walk-in patients for physical visit to the New OPD which was earlier stopped will now be started and will be done from 9.15 am to 11 am at the respective registration counters.

Advertisement

Online registration for physical visit to all OPDs which is currently capped at 30 patients per department will be increased to 50 for all departments and 100 for Opthalmology, Hepatology & Internal Medicine.

The institute requests the public visiting OPDs of PGIMER to follow all Covid appropriate behaviour. The fight against Covid-19 is still on and large gatherings of people can lead to its spread, PGIMER said in a statement.

Advertisement
Show comments
Advertisement